ArticleJournal of health, population, and nutrition2025
Investigation and response to a type 3 vaccine-derived poliovirus detected in an infant with hand, foot, and mouth disease - Guangdong, China, 2023.
Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe detection of type 3 vaccine-derived poliovirus (VDPV3) in an immunocompetent infant with hand, foot, and mouth disease (HFMD) raised concerns about potential transmission. This study aimed to investigate the risk of VDPV3 spread through comprehensive clinical, environmental, and epidemiological assessments. Existing literature highlights the rare emergence of VDPV3 in similar settings, emphasizing the need for robust surveillance and rapid response to prevent outbreaks. CASE PRESENTATION: Stool specimen from an 8-month-old female infant presented with HFMD without paralysis or immunodeficiency was tested positive for VDPV3 with 12 nucleotide changes in Foshan City. The infant had received routine vaccinations before and was otherwise healthy. No additional VDPV3 was detected in her follow-up samples, and the child fully recovered without complications. MEASURES: A team was formed to investigate and respond in accordance with China's National Health Commission and World Health Organization guidelines. Investigation included obtaining stool specimens from the child, her contacts, and local healthy children to test for evidence of poliovirus; conducting enhanced environmental surveillance for VDPV3 in wastewater; measuring vaccination coverage; searching hospitals and communities for unreported acute flaccid paralysis (AFP) cases; and evaluating the index infant for immunodeficiency.
resultsNo additional VDPV3s were detected in stool samples from the index infant, her contacts, or local healthy children. Similarly, no VDPV3s were identified in wastewater samples. The child's immune function was found to be normal. Historical vaccination coverage data revealed that Foshan had a high polio vaccination rate. An active search for AFP cases yielded no results. Over a period of more than one year, enhanced AFP surveillance and environmental surveillance were implemented, and no additional VDPV3s were detected during this time.
conclusionsBased on Foshan's high polio vaccine coverage rate, sensitive AFP case reporting system, and findings from the investigation, risk of transmission of VDPVs in the area was determined to be extremely low. No vaccination response was conducted. After one year of environmental and AFP surveillance, no further VDPV3s were detected, indicating cessation of transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.